In the Boardroom
Refine Search
Pharmaceutical
The UK’s leading pharmaceutical trade body, the Association of the British Pharmaceutical Industry (ABPI), has appointed Pfizer UK’s managing director Erik Nordkamp as president. 6 July 2018
Biotechnology
Belgian biotech firm iTeos Therapeutics has appointed Scott Chappel as its chief scientific officer (CSO). 3 July 2018
Biotechnology
Chugai Pharma Europe, a wholly-owned subsidiary of Chugai Pharmaceutical and its majority owner Roche, has announced the hiring of Troy Robinson as managing director of its UK operations. 3 July 2018
Pharmaceutical
Danish CNS specialist Lundbeck has appointed Dr Deborah Dunsire as new president and CEO of Lundbeck. Dr Dunsire will take up her new position on September 1, 2018. 2 July 2018
Pharmaceutical
In a major restructuring, privately-held Switzerland-based healthcare company Roivant Sciences has created two new business units, Roivant Pharma and Roivant Health, to focus its efforts on accelerating the launch of new innovative healthcare companies, including ‘Vants’ oriented around earlier-stage scientific platforms. 28 June 2018
Biotechnology
Tilos Therapeutics, a biotech firm developing anti-LAP antibodies for the treatment of cancer, fibrosis and autoimmune diseases, today announced the appointment of Jessie English as chief scientific officer. 27 June 2018
Biotechnology
Norwegian biotech firm Nordic Nanovector has appointed Eduardo Bravo as its chief executive. 25 June 2018
Pharmaceutical
US health care giant Johnson & Johnson has announced the appointment of a number of senior leaders to the company's executive committee. 25 June 2018
Pharmaceutical
Roche today announced that Sophie Kornowski-Bonnet, head of Roche Partnering and member of the enlarged corporate executive committee (CEC) since 2012, has accepted a new opportunity and will be leaving the company effective July 31, 2018. 22 June 2018
Pharmaceutical
French pharma major Sanofi has appointed Jean-Baptiste Chasseloup de Chatillon as executive vice president, chief financial officer (CFO) and member of the executive committee, effective October 1, 2018. 19 June 2018
Biotechnology
China’s Zai Lab, a Shanghai-based innovative biopharmaceutical company, has appointed that William Liang as chief commercial officer, reporting to Dr Samantha Du, Zai Lab’s chief executive. 11 June 2018
Pharmaceutical
French independent pharma company Servier today announced the appointments of Christian Schubert and Rekha Paleyanda as directors of Servier BioInnovation along with the opening of the Servier BioInnovation office in Cambridge, Massachusetts. 7 June 2018
Biotechnology
The Cell and Gene Therapy (CGT) Catapult announced on Wednesday the appointment of a new chief scientific officer. 6 June 2018
Biotechnology
Andrew Dickinson has been named Gilead Sciences’ executive vice president, corporate development and strategy. 5 June 2018
Generics
Jordan-based drugmaker Hikma Pharmaceuticals has appointed Henriette Nielsen to the newly-created role of chief transformation officer. 4 June 2018
Biotechnology
US biotech major Biogen has appointed Daniel Karp as executive vice president, corporate development effective June 11, 2018. 1 June 2018
Biotechnology
In what is becoming a growing trend, another big pharma senior executive has left to take on a position with a growing biotechnology company, this time to the advantage of Cambridge, Massachusetts-based Axcella Health and loss for Swiss giant Novartis. 31 May 2018
Biotechnology
Ritter Pharmaceuticals has announced the hiring of John Beck as chief financial officer. 30 May 2018
Pharmaceutical
Privately-held dermatology specialist LEO Pharma today announced that Dr Christian Antoni has been appointed as senior vice president for global development at the Danish firm as of June 1, 2018. 29 May 2018
Biotechnology
Swiss immuno-oncology firm Nouscom today announced the appointment of Adrian Woolfson as chief medical officer (CMO). 29 May 2018
Biotechnology
US clinical-stage drug developer Acumen Pharmaceuticals has appointed Amy Schacterle as chief regulatory officer and head of quality, reporting to Jim Doherty, president and chief development officer at Acumen. 7 November 2024
Biotechnology
Memo Therapeutics, a privately-held Swiss biotech company translating unique responses into superior medicines to treat viral infections and cancer, has appointed a new chief development officer (CDO). 4 November 2024
Biotechnology
Netherlands-based Tessellate BIO, a pre-clinical stage biotech with a focus on novel synthetic lethality approaches, today announced the appointment of Dr Lara Boyd as chief business officer. 4 November 2024
Biotechnology
US biotech major Biogen revealed it has appointed Daniel Quirk as chief medical officer and head of medical affairs. 29 October 2024
Pharmaceutical
Fennec Pharmaceuticals has announced the addition of three new executives to bolster its leadership team as the company prepares for expanded commercial operations. 28 October 2024
Biotechnology
AAVantgarde has announced the appointment of Lauren Kaskiel as chief business officer (CBO). 22 October 2024
Pharmaceutical
British artificial intelligence specialist BenevolentAI has announced the return of its founder, Ken Mulvany, as executive chairman. 18 October 2024
Biotechnology
Denmark’s Commit Biologics, a specialist in the activation of the complement system to treat cancer and autoimmune disease, has announced the appointment of Mikkel Wandahl Pedersen as chief scientific officer (CSO). 15 October 2024
Pharmaceutical
Canada-based biotech Sernova (TSX: SVA) has announced key new appointments to its executive leadership team. 15 October 2024
Biotechnology
French biotech Innate Pharma has appointed Jonathan Dickinson as its new chief executive (CEO) and chairman of the executive board, effective November 1, 2024. 14 October 2024
Biotechnology
Turnstone Biologics has announced a major restructuring of its operations, cutting its workforce by approximately 60%. 14 October 2024
Pharmaceutical
Cancer start-up Black Diamond Therapeutics has announced a significant restructuring as part of its plan to focus resources on its lead drug, BDTX-1535. 10 October 2024
Biotechnology
Calluna Pharma, a biotech focused on treating inflammatory and fibrotic diseases, has appointed Mark Gaffney as its new chief executive. 9 October 2024
Biotechnology
Privately-held UK biotech Curve Therapeutics has announced the appointment of Rab Prinjha as chief research and development (R&D) officer. 9 October 2024
Biotechnology
French cancer vaccine focused biotech Oncovita has appointed Dr Stéphane Altaba as its new chief executive (CEO). 9 October 2024
Biotechnology
Cambridge, USA-based biotech Judo Bio has announced the company’s launch and $100 million in initial financing, including seed financing and Series A. 7 October 2024
Biotechnology
Mosaic Therapeutics, a UK-based oncology therapeutics company dedicated to resolving cancer’s complexity to power new combination therapies for patients, has announced the appointment of Barry Davies as chief scientific officer. 7 October 2024
Pharmaceutical
US pharma giant Pfizer (NYSE: PFE) has announced that John McGinley has been appointed UK managing director and country president. 7 October 2024
Pharmaceutical
ViroCell Biologics, a UK contract development and manufacturing organization (CDMO), has announces the appointment of Nicholas Ostrout, as vice president of corporate development and strategy. 7 October 2024
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze